Infinant Health
By Infinant Health
on February 15, 2023
Prospective study designed to assess the immunological effect of a specific B. infantis strain on the incidence of atopic dermatitis, one of the most prevalent pediatric allergic diseases.
Infinant Health
By Infinant Health
on February 06, 2023
As with adults, infants’ gut bacteria are less diverse than ever, which may play a role in disease progression later in life. C-sections and antibiotics may be partly to blame.
Infinant Health
By Infinant Health
on January 19, 2023
Former Infinant Health, Inc Board Member Mike Johnson will lead the company as it continues to spearhead innovative advancements in science surrounding infant health
Infinant Health
By Infinant Health
on November 09, 2022
Partnership Includes Three Strategic Pillars that Target Inflammatory and Autoimmune Diseases with Traces to Infancy
Infinant Health
By Infinant Health
on October 03, 2022
Evolve Biosystems becomes Infinant Health – powerful evolution of mission, leadership, portfolio & commercialization.
Infinant Health
By Infinant Health
on January 19, 2022
Study Published in Journal of Pediatrics Discusses Potential for Improved Clinical Care Associated with Administration of B. infantis EVC001 in Very Low Birth Weight Infants
Infinant Health
By Infinant Health
on March 26, 2020
Study aims to investigate whether infant probiotic Evivo can reduce development of early childhood atopic dermatitis, which is implicated in asthma, allergic rhinitis and food allergies, and affects ...